271 related articles for article (PubMed ID: 16482086)
1. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway.
García-Fuster MJ; Miralles A; García-Sevilla JA
Neuropsychopharmacology; 2007 Feb; 32(2):399-411. PubMed ID: 16482086
[TBL] [Abstract][Full Text] [Related]
2. Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: functional interactions with casein kinase Ialpha, Galpha(i) proteins, and ERK1/2 signaling.
García-Fuster MJ; Ramos-Miguel A; Miralles A; García-Sevilla JA
Neuropharmacology; 2008 Oct; 55(5):886-99. PubMed ID: 18657552
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
Asensio VJ; Miralles A; García-Sevilla JA
Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
[TBL] [Abstract][Full Text] [Related]
4. Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: a delta-opioid tone inhibits FADD.
García-Fuster MJ; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R; García-Sevilla JA
Eur Neuropsychopharmacol; 2007 Apr; 17(5):366-74. PubMed ID: 17030115
[TBL] [Abstract][Full Text] [Related]
5. Correlation of rat cortical Fas-associated death domain (FADD) protein phosphorylation with the severity of spontaneous morphine abstinence syndrome: role of α(2)-adrenoceptors and extracellular signal-regulated kinases.
Ramos-Miguel A; Miralles A; García-Sevilla JA
J Psychopharmacol; 2011 Dec; 25(12):1691-702. PubMed ID: 21088039
[TBL] [Abstract][Full Text] [Related]
6. The time course of unconditioned morphine-induced psychomotor sensitization mirrors the phosphorylation of FADD and MEK/ERK in rat striatum: role of PEA-15 as a FADD-ERK binding partner in striatal plasticity.
Ramos-Miguel A; Esteban S; García-Sevilla JA
Eur Neuropsychopharmacol; 2010 Jan; 20(1):49-64. PubMed ID: 19758790
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.
Ramos-Miguel A; García-Sevilla JA
Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain.
García-Fuster MJ; Ferrer-Alcón M; Miralles A; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):421-31. PubMed ID: 14530904
[TBL] [Abstract][Full Text] [Related]
9. Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain.
Boronat MA; García-Fuster MJ; García-Sevilla JA
Br J Pharmacol; 2001 Nov; 134(6):1263-70. PubMed ID: 11704646
[TBL] [Abstract][Full Text] [Related]
10. Roles of different subtypes of opioid receptors in mediating the ventrolateral orbital cortex opioid-induced inhibition of mirror-neuropathic pain in the rat.
Zhao M; Wang JY; Jia H; Tang JS
Neuroscience; 2007 Feb; 144(4):1486-94. PubMed ID: 17184926
[TBL] [Abstract][Full Text] [Related]
11. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of FADD (Fas-associated death domain protein) at serine 194 is increased in the prefrontal cortex of opiate abusers: relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15 kDa, and Akt signaling pathways involved in neuroplasticity.
Ramos-Miguel A; García-Fuster MJ; Callado LF; La Harpe R; Meana JJ; García-Sevilla JA
Neuroscience; 2009 Jun; 161(1):23-38. PubMed ID: 19303913
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R
Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676
[TBL] [Abstract][Full Text] [Related]
14. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
[TBL] [Abstract][Full Text] [Related]
15. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
18. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
19. Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes.
Onali P; Dedoni S; Olianas MC
J Pharmacol Exp Ther; 2010 Jan; 332(1):255-65. PubMed ID: 19828880
[TBL] [Abstract][Full Text] [Related]
20. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
